Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study
- PMID: 22172445
- PMCID: PMC3375331
- DOI: 10.1016/j.ahj.2011.09.029
Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study
Abstract
Background: We sought to investigate whether higher concentrations of resistin and lower concentrations of adiponectin relate to incident atrial fibrillation (AF) and whether this association is mediated by AF risk factors and inflammation. Resistin and adiponectin are adipokines that have been associated with multiple known risk factors for AF including diabetes, obesity, inflammation, and heart failure.
Methods: We studied the relations between circulating concentrations of both adipokines and incident AF in participants of the Framingham Offspring Study.
Results: Participants (n = 2,487) had a mean age of 61 ± 10 years, and 54% were women. During a mean follow-up of 7.6 ± 2.0 years, 206 (8.3%) individuals (96 women) developed incident AF. Plasma resistin concentration was significantly associated with incident AF (multivariable-adjusted hazard ratio [HR] 1.17 per SD [0.41 ng/mL] of natural logarithmically transformed resistin, 95% CI 1.02-1.34, P = .028). The resistin-AF association was attenuated after further adjustment for C-reactive protein (HR per SD increase resistin 1.14, 95% CI 0.99-1.31, P = .073). Adiponectin concentrations were not significantly associated with incident AF (multivariable-adjusted HR of 0.95 per SD [0.62 μg/mL] of logarithmically transformed adiponectin, 95% CI 0.81-1.10, P = .478).
Conclusion: In our community-based longitudinal study, higher mean concentrations of resistin were associated with incident AF, but the relation was attenuated by adjustment for C-reactive protein. We did not detect a statistically significant association between adiponectin and incident AF. Additional studies are needed to clarify the potential role of adipokines in AF and mechanisms linking adiposity to AF.
Copyright © 2012 Mosby, Inc. All rights reserved.
Figures

Similar articles
-
The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women.Heart. 2016 Sep 1;102(17):1354-62. doi: 10.1136/heartjnl-2015-308927. Epub 2016 May 4. Heart. 2016. PMID: 27146694
-
Resistin, adiponectin, and risk of heart failure the Framingham offspring study.J Am Coll Cardiol. 2009 Mar 3;53(9):754-62. doi: 10.1016/j.jacc.2008.07.073. Epub 2008 Dec 26. J Am Coll Cardiol. 2009. PMID: 19245965 Free PMC article.
-
Are adipokines associated with atrial fibrillation in type 2 diabetes?Endokrynol Pol. 2020;71(1):34-41. doi: 10.5603/EP.a2019.0059. Endokrynol Pol. 2020. PMID: 33140400
-
Associations between adipokines and atrial fibrillation: A systematic review and meta-analysis.Nutr Metab Cardiovasc Dis. 2022 Apr;32(4):853-862. doi: 10.1016/j.numecd.2022.01.019. Epub 2022 Jan 23. Nutr Metab Cardiovasc Dis. 2022. PMID: 35227548
-
Serum Leptin, Resistin, and Adiponectin Concentrations in Psoriasis: A Meta-Analysis of Observational Studies.Dermatology. 2017;233(5):378-389. doi: 10.1159/000481882. Epub 2017 Dec 13. Dermatology. 2017. PMID: 29232663 Review.
Cited by
-
Clinical implications of serum adiponectin on progression of atrial fibrillation.J Arrhythm. 2017 Dec;33(6):608-612. doi: 10.1016/j.joa.2017.07.009. Epub 2017 Sep 13. J Arrhythm. 2017. PMID: 29255509 Free PMC article.
-
A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study.Eur J Epidemiol. 2014 Mar;29(3):181-90. doi: 10.1007/s10654-013-9875-y. Epub 2014 Jan 4. Eur J Epidemiol. 2014. PMID: 24389686
-
Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults.Heart. 2015 Sep;101(17):1368-74. doi: 10.1136/heartjnl-2014-307015. Epub 2015 Apr 8. Heart. 2015. PMID: 25855796 Free PMC article.
-
Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion.Biomedicines. 2023 May 16;11(5):1452. doi: 10.3390/biomedicines11051452. Biomedicines. 2023. PMID: 37239123 Free PMC article. Review.
-
Mechanisms of Chronic Metabolic Stress in Arrhythmias.Antioxidants (Basel). 2020 Oct 19;9(10):1012. doi: 10.3390/antiox9101012. Antioxidants (Basel). 2020. PMID: 33086602 Free PMC article. Review.
References
-
- Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–125. - PubMed
-
- Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N–9N. - PubMed
-
- Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart study. JAMA. 1994;271:840–844. - PubMed
-
- Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med. 1995;98:476–484. - PubMed
-
- Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455–2461. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- 1RC1HL101056/HL/NHLBI NIH HHS/United States
- R01 HL104156/HL/NHLBI NIH HHS/United States
- RC1 HL101056/HL/NHLBI NIH HHS/United States
- L30 HL097675/HL/NHLBI NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- R01 HL102214/HL/NHLBI NIH HHS/United States
- K24 DK080140/DK/NIDDK NIH HHS/United States
- 1K24HL105780/HL/NHLBI NIH HHS/United States
- 1R01HL102214/HL/NHLBI NIH HHS/United States
- 5R21DA027021/DA/NIDA NIH HHS/United States
- R21 DA027021/DA/NIDA NIH HHS/United States
- R01 NS017950/NS/NINDS NIH HHS/United States
- K24 HL105780/HL/NHLBI NIH HHS/United States
- R01-DK-080739/DK/NIDDK NIH HHS/United States
- R01 HL092577/HL/NHLBI NIH HHS/United States
- R01AG028321/AG/NIA NIH HHS/United States
- R01 DK080739/DK/NIDDK NIH HHS/United States
- 1R01HL092577/HL/NHLBI NIH HHS/United States
- R01 AG028321/AG/NIA NIH HHS/United States
- 5R01HL104156/HL/NHLBI NIH HHS/United States
- 6R01-NS17950/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials